The UK NSC recommendation on Familial Hypercholesterolaemia screening in adults (currently under review)
This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.
The review process began in Oct 2014 and is estimated to be completed by Jun 2015.
||Systematic population screening programme not recommended
A national screening programme for FH is not recommended.
Find general information about population health screening.
More about Familial Hypercholesterolaemia (adult)
Familial hypercholesterolaemia (or hyperlipidaemias) are inherited metabolic disorders which include harmful disorders resulting in an excess of cholesterol and/or triglyceride in the blood. Cholesterol is transported round the body in combination with proteins, known as lipoproteins, low density lipoproteins (LDL) and beneficial high density lipoproteins (HDL). Triglyceride travels within very low density lipoproteins (VLDL) and chylomicrons.
» Read more about familial hypercholesterolaemia on NHS Choices
• British Heart Foundation
• British Inherited Metabolic Disease Group
• Genetic Alliance UK
• HEART UK
• Royal College of Pathologists
• Royal College of Physicians
• Royal College of Physicians and Surgeons of Glasgow
• Royal College of Physicians of Edinburgh
• Scottish Lipid Forum
The stakeholder groups will be involved when the recommendation is next reviewed.
If you think your organisation should be added, please
More about the recommendation review process, including the role of stakeholders,
can be found in the guide to Engaging with the UK NSC's recommendation review process.
Summary of Policy and Consultation Responses for Familial Hypercholesterolaemia (PDF document, 598KB, 15/12/11)
More optionsGo to top